A Randomized Pilot Study of SRL172 (Mycobacterium vaccae) in Patients with Small Cell Lung Cancer (SCLC) Treated with Chemotherapy
- 1 February 2002
- journal article
- clinical trial
- Published by Elsevier in Clinical Oncology
- Vol. 14 (1) , 23-27
- https://doi.org/10.1053/clon.2001.0030
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- A randomized phase II study of SRL172 (Mycobacterium vaccae) combined with chemotherapy in patients with advanced inoperable non-small-cell lung cancer and mesotheliomaBritish Journal of Cancer, 2000
- Lung cancer: Update on the treatment of small cell lung cancer (SCLC)Annals of Oncology, 2000
- New Chemotherapy Agents for Small Cell Lung CancerChest, 2000
- Possible improved survival of patients with stage IV AJCC melanoma receiving SRL 172 immunotherapy: Correlation with induction of increased levels of intracellular interkukin-2 in peripheral blood lymphocytesAnnals of Oncology, 1999
- Treatment of small cell lung cancer patientsAnnals of Oncology, 1999
- Immunotherapy of advanced prostate cancer: a phase I/II trial using Mycobacterium vaccae (SRL172)British Journal of Urology, 1998
- A pilot study of MVP (mitomycin-C, vinblastine and cisplatin) chemotherapy in small-cell lung cancerBritish Journal of Cancer, 1998